Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene

Author：        

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.29, Iss.4, 2013-01, pp. : 1666-1670

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer

By              

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 59-66

Spandidos Publications

Access to resources Recommend Favorite

The glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant glioma

By          

Oncology Letters, Vol. 5, Iss. 2, 2013-01 ,pp. : 669-674

Spandidos Publications

Access to resources Recommend Favorite

AFP Promoter Enhancer Increased Specific Expression of the Human Sodium Iodide Symporter (hNIS) for Targeted Radioiodine Therapy of Hepatocellular Carcinoma

By Ma Xiao-Juan   Huang Rui   Kuang An-Ren  

Cancer Investigation, Vol. 27, Iss. 6, 2009-07 ,pp. : 673-681

Informa Healthcare

Access to resources Recommend Favorite

Study on molecular imaging and radionuclide therapy of human nasopharyngeal carcinoma cells transfected with baculovirus-mediated sodium/iodine symporter gene

By              

International Journal of Oncology, Vol. 43, Iss. 1, 2013-01 ,pp. : 177-184

Spandidos Publications

Access to resources Recommend Favorite

Sodium iodide symporter in the fight against thyroid cancer

By Kogai Takahiko  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1679-1682

Future Medicine

Access to resources Recommend Favorite